Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan
Background/Aims
The infectivity of occult hepatitis B virus (HBV), defined as HBsAg-negative but HBV DNA-positive, after transfusion has been low but not negligible. To address this, we investigated the incidence of post-transfusion HBV infection after receiving screened blood units in Taiwan.
Methods
Consecutive HBV-naïve (anti-HBc-negative) recipients with normal ALT were followed for HBV DNA and serologic markers before and after transfusion. Among 4448 blood recipients, 467 (10.5%) were anti-HBc-negative. Post-transfusion 6-month follow-up was completed for 327. We identified 5 (1.5%) who developed hepatitis B viremia 1 week after transfusion. Three were children who later seroconverted to anti-HBc but with normal ALT indicating subclinical acute infection, despite all had anti-HBs from previous vaccination. One had transient transfusion-transmitted HBV without seroconversion to anti-HBc and one possibly had occult HBV infection. Our findings suggested the possibility that occult HBV infection was transmissible by transfusion. The incidence of post-transfusion acute HBV infection was 0.9% (100 per million units) in naïve recipients in Taiwan, a figure 7∼40-fold higher than in developed countries. Moreover, some vaccinated children with anti-HBs were still susceptible.
Conclusions
Therefore, despite active immunization, sensitive screening assays for occult HBV infection such as nucleic acid amplification test could be considered in endemic areas.
Keywords: Occult hepatitis B virus, transfusion, HBV DNA, anti-HBc
Abbreviations: ALT, alanine aminotransferase, Anti-HBc, antibody to hepatitis B core antigen, Anti-HBe, antibody to hepatitis B e antigen, Anti-HBs, antibody to hepatitis B surface antigen, HBe, hepatitis B e antigen, HBsAg, hepatitis B surface antigen, HBV, hepatitis B virus, NAT, nucleic acid amplification test, PCR, polymerase chain reaction
To access this article, please choose from the options below
PII: S0168-8278(05)00449-6
doi:10.1016/j.jhep.2005.06.016
© 2005 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
